The DOI matches its Crossref record; 154 of the 156 references it cites were found in a registry or an index.
Danger-associated molecular patterns in Alzheimer’s disease
Open accessAbstract
Pathogen-associated molecular patterns (PAMPs) and endogenous “danger” signals, known as danger-associated molecular patterns (DAMPs), released from cells alert the innate immune system and activate several signal transduction pathways through interactions with the highly conserved pattern recognition receptors (PRRs). Both PAMPs and DAMPs directly induce proinflammatory cascades and trigger the formation of the inflammasome, mediating the release of cytokines. Here, we highlight the role of DAMPs, including amyloid β (Aβ), high-mobility group box 1 (HMGB1), the S100 family proteins, chromogranin A, and nucleic acids, in the innate-immune activation during the course of Alzheimer disease (AD), the most frequent neurodegenerative disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition to aggregates, tissue injury also induces the extracellular release of DAMPs, such as mitochondrial DNA (mtDNA), high mobility group box 1 (HMGB1), S100 proteins, chromogranin A, adenosine 5′-triphosphate (ATP), and uric acid, from damaged brain cells. These DAMPs trigger neuroinflammation by activating pattern recognition receptors (PRRs), including TLRs, RAGE, NLRs, P2Y receptors”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [48]
Experimental — accuracy not yet measuredIn the citing paper
“PRRs bind to different species of Aβ with various affinities (71).”
From Microglia in Alzheimer's disease (2017) · cites this paper as [71]
In the citing paper
“In AD, Aβ can act as DAMP and its interaction with microglia creates an oxidative and neuroinflammatory environment through an increased production of ROS and release of proinflammatory cytokines [107].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [107]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Yang, H., Lundbäck, P., Ottosson, L., Erlandsson-Harris, H., Venereau, E., Bianchi, M. E., Al-Abed, Y., Andersson, U., Tracey, K. J., & Antoine, D. J. (2012) · Molecular Medicine · doi:10.2119/molmed.2011.00389 · Cited by 407
RetractedThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
Self-citationTolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,848
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
Circulating mitochondrial DAMPs cause inflammatory responses to injury
Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., Brohi, K., Itagaki, K., & Hauser, C. J. (2010) · Nature · doi:10.1038/nature08780 · Cited by 3,812
Toll-like receptors in innate immunity
Takeda, K. (2004) · International Immunology · doi:10.1093/intimm/dxh186 · Cited by 3,328
Research works printed but not linked: 2
- Wyss-Coray, 2006, Inflammation in Alzheimer disease: driving force, bystander or beneficial response, Nat. Med., 12, 1005
- Scholtzova, 2014, Amyloid β and tau Alzheimer’s disease related pathology is reduced by Toll-like receptor 9 stimulation, Acta Neuropathol. Commun., 2, 101
Cited by
Sorted by citations
Items 101–200 of 236
Emerging Roles of Cells and Molecules of Innate Immunity in Alzheimer’s Disease
Tamburini, B., Badami, G. D., Manna, M. P. L., Azgomi, M. S., Caccamo, N., & Dieli, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511922 · Cited by 22
Small molecule therapeutics for neuroinflammation-mediated neurodegenerative disorders
Miller, S., & Blanco, M.-J. (2021) · RSC Medicinal Chemistry · doi:10.1039/d1md00036e · Cited by 21
Weng, L., Guo, L., Vachani, A., Mesaros, C., & Blair, I. A. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b01175 · Cited by 23
Jafari, R., Aflatoonian, R., Falak, R., Pourmand, G., Dehghani, S., Mortazavi, M., Adelipour, A., Rezaei, A., & Tajik, N. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.12.012 · Cited by 20
Pathogenesis, Animal Models, and Drug Discovery of Alzheimer’s Disease
Xia, Z.-D., Ma, R.-X., Wen, J.-F., Zhai, Y.-F., Wang, Y.-Q., Wang, F.-Y., Liu, D., Zhao, X.-L., Sun, B., Jia, P., et al. (2023) · Journal of Alzheimer's Disease · doi:10.3233/jad-230326 · Cited by 19
Sleep Disturbance and Alzheimer’s Disease: The Glial Connection
Sunkaria, A., & Bhardwaj, S. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03578-0 · Cited by 19
Bonomi, C. G., Assogna, M., Donna, M. G. D., Bernocchi, F., Lucia, V. D., Nuccetelli, M., Fiorelli, D., Loizzo, S., Mercuri, N. B., Koch, G., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221010 · Cited by 20
Yadav, V., Mythri, C., & Kumarasamy, M. (2024) · Brain Behavior and Immunity Integrative · doi:10.1016/j.bbii.2024.100048 · Cited by 22
S100 proteins as a key immunoregulatory mechanism for NLRP3 inflammasome
Acter, S., & Lin, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1663547 · Cited by 19
An overview on microglial origin, distribution, and phenotype in Alzheimer's disease
Islam, R., Choudhary, H. H., Rajan, R. G., Vrionis, F. D., & Hanafy, K. A. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30829 · Cited by 18
Exploring the effect of gut microbiome on Alzheimer's disease
Pourahmad, R., Saleki, K., Zare, M., Aram, C., Farsani, A. S., Banazadeh, M., & Tafakhori, A. (2024) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2024.101776 · Cited by 20
Trajectory of Cardiogenic Dementia: A New Perspective
Alrawili, N. F., Al-Kuraishy, H. M., Al-Gareeb, A. I., Abdel‐Fattah, M. M., Al‐Harchan, N. A., Alruwaili, M., Papadakis, M., Alexiou, A. T., & Batiha, G. E. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70345 · Cited by 17
Characterising lipoteichoic acid as an in vitro model of acute neuroinflammation
Howe, A.-M., Cosgrave, A., Murchú, M. Ó., Britchfield, C., Mulvagh, A., Fernández-Pérez, I., Dykstra, M., Jones, A. C., & Costello, D. A. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106619 · Cited by 17
Microglia activation linking amyloid-β drive tau spatial propagation in Alzheimer's disease
Wang, Q., & Xie, C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.951128 · Cited by 20
Wenzel, T. J., Kwong, E. H., Bajwa, E., & Klegeris, A. (2020) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527319666200702143719 · Cited by 16
Patten, K. T., Valenzuela, A. E., Wallis, C., Harvey, D. J., Bein, K. J., Wexler, A. S., Gorin, F. A., & Lein, P. J. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.861733 · Cited by 17
LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD
Guan, F., Gao, Q., Gu, J., Dai, X., Li, L., & Bao, R. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.824495 · Cited by 17
Wang, W., Wang, L., Zhong, X., Dong, L., Zhang, L., & Hu, J. X. (2025) · Cell Biochemistry and Function · doi:10.1002/cbf.70146 · Cited by 15
Increased cysteinyl-tRNA synthetase drives neuroinflammation in Alzheimer’s disease
Qi, X.-H., Chen, P., Wang, Y., Zhou, Z.-P., Liu, X., Fang, H., Wang, C., Liu, J., Liu, R., Liu, H., et al. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-023-00394-6 · Cited by 15
Pharmacogenomics for neurodegenerative disorders - a focused review
Ahmad, S. R., Zeyaullah, M., Khan, M. S. A. A., AlShahrani, A. M., Altijani, A. A. G., Ali, H., Dawria, A., Mohieldin, A., Alam, M. S., & Mohamed, A. O. A. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1478964 · Cited by 17
Kung, W., & Lin, M.-S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073289 · Cited by 14
Neutrophil Granule Proteins Inhibit Amyloid Beta Aggregation and Neurotoxicity
Kasus‐Jacobi, A., Washburn, J. L., Land, C. A., & Pereira, H. A. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666210823095044 · Cited by 15
Steinberg, N., Galleguillos, D., Zaidi, A. K., Horkey, M., & Sipione, S. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02963-y · Cited by 14
The intricate interplay between microglia and adult neurogenesis in Alzheimer’s disease
Früholz, I., & Meyer‐Luehmann, M. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1456253 · Cited by 16
Role of NLRP3 Inflammasome in Chronic Pain and Alzheimer's Disease—A Review
Moradi, F., & Mokhtari, T. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70071 · Cited by 14
Xue, F., Zhang, M., Zhao, R.-Y., Wang, X., Gu, Y., Yang, Y., & Chen, W. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.02.013 · Cited by 17
Manole, E., Dumitrescu, L., Niculite, C. M., Popescu, B. O., & Ceafalan, L. C. (2021) · Biocell · doi:10.32604/biocell.2021.013452 · Cited by 14
Kung, W., & Lin, M.-S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020934 · Cited by 14
Inflammation in the CNS: Understanding Various Aspects of the Pathogenesis of Alzheimer's Disease
Doroszkiewicz, J., Mroczko, P., & Kulczyńska‐Przybik, A. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666211202143935 · Cited by 14
Zsuzsa, M., Jenei, V., Mácsik, R., Mezhonova, E., Diyab, S., Csősz, R., Bácsi, A., Mázló, A., & Koncz, G. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07563-7 · Cited by 14
Rezk, S., Lashen, S., El‐Adl, M., Elshopakey, G. E., Elghareeb, M. M., Hendam, B. M., Caceci, T., Cenciarelli, C., & Marei, H. E. S. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-021-00890-6 · Cited by 12
RetractedCómitre-Mariano, B., Vellila-Alonso, G., Segura‐Collar, B., Mondéjar-Ruescas, L., Sepúlveda-Sánchez, J. M., & Gargini, R. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03298-y · Cited by 16
Lee, H. J., Savelieff, M. G., Kang, J., Brophy, M. B., Nakashige, T. G., Lee, S. J. C., Nolan, E. M., & Lim, M. H. (2018) · Metallomics · doi:10.1039/c8mt00091c · Cited by 12
Aging-induced alterations in microglial cells and their impact on neurodegenerative disorders
Singh, H., Gupta, R., Gupta, M., & Ahmad, A. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10623-y · Cited by 11
Kumar, P., Mathew, S., Gamage, R. V., Bodkin, F., Doyle, K., Rosetti, I., Wagnon, I. M., Zhou, X., Raju, R., Gyengési, E., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311086 · Cited by 12
S100B inhibition protects from chronic experimental autoimmune encephalomyelitis
Barros, C., Barateiro, A. P., Neto, A., Soromenho, B., Basto, A. P., Mateus, J. M., Xapelli, S., Sebastião, A. M., Brites, D. M. T. O., Graça, L., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac076 · Cited by 10
Mechanistic Approach to Immunity and Immunotherapy of Alzheimer’s Disease: A Review
Islam, M. R., Rabbi, M. A., Hossain, T., Sultana, S., & Uddin, S. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00360 · Cited by 10
Villacampa, N., Sarlus, H., Martorell, P., Bhalla, K., Castro‐Gomez, S., Vieira-Saecker, A. M. M., Slutzkin, I., Händler, K., Venegas, C., McManus, R. M., et al. (2025) · ASN NEURO · doi:10.1080/17590914.2025.2506406 · Cited by 11
Self-citationEl-Taibany, A. A., Heydarian, P., Porada, D. A., Seeds, M. C., & Atala, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1595276 · Cited by 11
Mannini, B., Vecchi, G., Labrador‐Garrido, A., Fabre, B., Fani, G., Franco, J. M., Lilley, K. S., Pozo, D., Vendruscolo, M., Chiti, F., et al. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00088 · Cited by 10
Neuroinflammation als Motor der Alzheimer-Erkrankung
Castro‐Gomez, S., Binder, J., & Heneka, M. T. (2019) · Der Nervenarzt · doi:10.1007/s00115-019-0778-3 · Cited by 11
Self-citationPro-neuroinflammatory and neurotoxic potential of extracellular histones H1 and H3
McRae, S. A., Richards, C. M., Silva, D. E. D., Riar, I., Yang, S., Zurfluh, N. E., Gibon, J., & Klegeris, A. (2024) · Neuroscience Research · doi:10.1016/j.neures.2024.01.004 · Cited by 12
López-Pérez, Ó., Bernal-Martin, M., Hernaiz, A., Llorens, F., Betancor, M., Otero, A., Toivonen, J. M., Zaragoza, P., Zerr, I., Badiola, J. J., et al. (2020) · Biomolecules · doi:10.3390/biom10050706 · Cited by 10
Selecting Multitarget Peptides for Alzheimer’s Disease
Kasus‐Jacobi, A., Washburn, J. L., Laurence, R. B., & Pereira, H. A. (2022) · Biomolecules · doi:10.3390/biom12101386 · Cited by 10
Paolo, M. D., Corsi, F., Cerri, C., Bisti, S., Piano, I., & Gargini, C. (2023) · Pharmaceuticals · doi:10.3390/ph16091307 · Cited by 9
Sarkar, S., Porel, P., Kosey, S., & Aran, K. R. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01697-y · Cited by 9
Amyloid Beta Peptides Lead to Mast Cell Activation in a Novel 3D Hydrogel Model
Liu, J., Liu, S., Zeng, L., & Tsilioni, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512002 · Cited by 12
Chernyak, B. V., Lyamzaev, K. G., & Mulkidjanian, A. Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413480 · Cited by 10
Bianchini, M. C., Franscescon, F., Soares, A. A., Ansolin, V., Pretto, K. P., da Cunha, M. L. V., & Silva, D. T. D. R. E. (2025) · Current Neuropharmacology · doi:10.2174/011570159x355614250130100132 · Cited by 8
Kakkar, A., Singh, H., Anand, A. K., Chopra, H., & Mishra, A. K. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128373290250620054118 · Cited by 8
The Adult Neurogenesis Theory of Alzheimer’s Disease
Abbate, C. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221279 · Cited by 11
Zagorski, K., King, O., Hovakimyan, A., Petrushina, I., Antonyan, T., Chailyan, G., Ghazaryan, M., Hyrc, K. L., Chadarevian, J. P., Davtyan, H., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129797 · Cited by 8
Ramakrishnan, S., Arshad, F., Bs, K., Pon, A. G., Bosco, S., Kumar, S., Chidambaram, H., Chinnathambi, S. C. B., Kulanthaivelu, K., Arunachal, G., et al. (2024) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000538145 · Cited by 8
Novel plasma protein biomarkers: A time-dependent predictive model for Alzheimer's disease
Zhuang, T., Yang, Y., Ren, H., Zhang, H., Gao, C. Q., Chen, S., Shen, J., Ji, M., & Cui, Y. (2024) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2024.105650 · Cited by 7
Андреевна, Л. Е., Shevelyova, M. P., Андреевна, В. А., Deryusheva, E. I., Валериевич, М. А., Леонидовна, Н. Е., Permyakova, M. E., Sokolov, A. S., Alikova, V. D., Uversky, V. N., et al. (2025) · Biomolecules · doi:10.3390/biom15030431 · Cited by 7
Cámara-Quílez, M., Barreiro-Alonso, A., Rodriguez-Belmonte, E. M., Varela, M. Q., Cerdán, M. E., & Maceiras, M. L. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190123120338 · Cited by 9
Lee, J. H., Ji, S. H., Lim, J. S., Ahn, S., Yun, H., Kim, S. H., & Song, J. S. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03777-9 · Cited by 8
Necrotic-like BV-2 microglial cell death due to methylmercury exposure
Martins, B., Novo, J. P., Fonseca, É., Raposo, R. D. S., Sardão, V. A., Pereira, F. C., Oriá, R. B., Fontes-Ribeiro, C., & Malva, J. O. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1003663 · Cited by 7
Montagud‐Romero, S., Miñarro, J., & Rodríguez‐Arias, M. (2021) · Current topics in behavioral neurosciences · doi:10.1007/7854_2021_260 · Cited by 7
Extracellular mixed histones are neurotoxic and modulate select neuroimmune responses of glial cells
Silva, D. E. D., Richards, C. M., McRae, S. A., Riar, I., Yang, S., Zurfluh, N. E., Gibon, J., & Klegeris, A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0298748 · Cited by 8
Singh, A. S., Naqvi, A. R., & Chanu, M. T. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2026.01.050 · Cited by 7
ApoE Isoforms Inhibit Amyloid Aggregation of Proinflammatory Protein S100A9
Ghosh, S., Tamilselvi, S., Williams, C., Jayaweera, S. W., Iashchishyn, I. A., Šulskis, D., Gilthorpe, J. D., Olofsson, A., Smirnovas, V., Svedružić, Ž. M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042114 · Cited by 6
Ho, G. J., Lam, L. Q., Tran, T. T., Wei, J., & Hashimoto, M. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1430593 · Cited by 7
Ghosh, S., Garcia, V., Singewald, K., Damo, S. M., & Saxena, S. (2018) · Applied Magnetic Resonance · doi:10.1007/s00723-018-1053-7 · Cited by 6
The therapeutic potential of early exercise in Alzheimer's disease: Focus on the brain-spleen axis
Wang, T., Feng, L., & Tian, Z. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102980 · Cited by 6
Liang, P., Wang, C. Y. Y., Liu, J., Huang, H., Li, Y., Kang, J., Li, G., & Wu, H. (2025) · Immunity Inflammation and Disease · doi:10.1002/iid3.70166 · Cited by 5
Coordinated Transcriptional Waves Define the Inflammatory Response of Primary Microglial Culture
Zohar, K., Lezmi, E., Reichert, F., Eliyahu, T., Rotshenker, S., Weinstock, M., & Linial, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310928 · Cited by 5
Exposure to Aluminum in Daily Life and Alzheimer’s Disease
Nie, J. (2023) · Springer eBooks · doi:10.1007/978-981-99-1592-7_6 · Cited by 5
Effects of Dietary Components on Microglia Inactivation in Alzheimer’s Disease
Bhatia, H. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811959-4.00008-0 · Cited by 5
Guo, Z., Zhong, S.-J., Bai, J.-P., Lang, X.-Y., Cao, M., Hu, Y., Qin, X., & Sun, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-05994-y · Cited by 4
Oh, M., & Weaver, D. F. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1106623 · Cited by 5
Pan, H.-L., Ge, J.-Y., Zhang, Z.-A., Xu, J., Wu, J., Ju, Y., Zhang, X.-Y., Jiang, Z.-J., Chen, Y., Xu, Y., et al. (2026) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2026.109016 · Cited by 3
Gupta, A. K., Singh, S., & Singh, T. D. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02324-0 · Cited by 3
Laadraoui, J., Kabdy, H., Oufquir, S., Aitlarradia, M., Agouram, F., Aitbaba, A., Oubella, K., & El‐Mansoury, B. (2025) · IGI Global eBooks · doi:10.4018/979-8-3693-9112-9.ch005 · Cited by 3
Alzheimer Hastalığı ve Anti-Alzheimer Etkili Bileşiklerin Yapılarının Araştırılması
Tari, O., & YAĞMURTAŞAN, R. (2023) · Hacettepe University Journal of the Faculty of Pharmacy · doi:10.52794/hujpharm.1175099 · Cited by 3
Identification of immunogenic cell death-related genes involved in Alzheimer’s disease
Wang, R., Du, Y., Shao, W., Wang, J., Liu, X., Xu, X., Chen, G., & Sun, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-54357-6 · Cited by 5
Lu, M., Ding, N., Wang, X., Cao, J., Jiang, J. H., Gao, Y., & Li, Z. (2019) · Journal of Traditional Chinese Medical Sciences · doi:10.1016/j.jtcms.2019.03.004 · Cited by 3
Vegh, C., Walach, G., Dube, K., Dobson, B., Talukdar, R., Wear, D., Jayawardena, H., Dufault, K., Culmone, L., Srikantha, S., et al. (2025) · Nutrients · doi:10.3390/nu17162701 · Cited by 2
Mustafa, A. M., Mudhafar, M., Elgindy, A. M., Esmail, M. M., Atwa, A. M., Shaheen, A. M., Radwan, A. E., Elfar, N., Mohamed, R. Y. A., & Gamil, N. M. (2026) · Archives of Pharmacal Research · doi:10.1007/s12272-026-01604-1 · Cited by 2
AI-driven insights into protein misfolding and innate immunity in neurodegenerative diseases
Deng, H. X., Cao, J. L., Yao, W., Jiang, S. J., Fang, Q. Q., Zhu, B. Y., & Jiang, Y. J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1814357 · Cited by 2
Wang, Q.-Q., Sun, Q.-Q., Guo, Y.-S., Yin, S., & Zhou, J. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00571-3 · Cited by 2
Toxoplasma gondii Infection of BALB /c Mice Perturbs Host Neurochemistry
Abdelsalam, A. A. A., Woods, S., Henriquez, S., Curran, L., Westrop, G. D., & Roberts, C. W. (2024) · Parasite Immunology · doi:10.1111/pim.13073 · Cited by 2
Tomita, K., Nakashima, K., Yamaguchi, E., Itoh, A., & Inoue, M. (2025) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b25-00037 · Cited by 2
Role of Stress, Immune System and Well-being in Patients with Alzheimer's Disease
García-Pardo, M. P., Rochina, M. J., & De La Rubia Orti, J. E. (2017) · Journal of Neurology and Neuroscience · doi:10.21767/2171-6625.1000171 · Cited by 2
Gadd, D. A., McGeachan, R. I., Hillary, R. F., McCartney, D. L., Harris, S. E., Sherwood, R. A., Abbott, N. J., Cox, S. R., & Marioni, R. E. (2021) · Wellcome Open Research · doi:10.12688/wellcomeopenres.17322.1 · Cited by 3
Role of caspases, apoptosis and additional factors in pathology of Alzheimer's disease
Gupta, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820122-0.00001-7 · Cited by 2
Microglial targets for effective therapies of Alzheimer’s disease
Klegeris, A. (2020) · Frontiers in Drug Chemistry and Clinical Research · doi:10.15761/fdccr.1000145 · Cited by 2
Gut–Brain Axis: Role of Gut Microbiota in Neurodegenerative Disease
Narang, A., & Sandhir, R. (2022) · Springer eBooks · doi:10.1007/978-981-16-6760-2_1 · Cited by 1
Gorina, Y. V., Lopatina, O. L., Komleva, Y. K., Черных, А. И., & Salmina, A. B. (2022) · Human Physiology · doi:10.1134/s0362119722080035 · Cited by 1
Gorina, Y. V., Lopatina, O. L., Komleva, Y. К., Chernikh, A. I., & Salmina, A. B. (2018) · Annals of Clinical and Experimental Neurology · doi:10.25692/acen.2018.2.4 · Cited by 1
Visualising the Knowledge Structure of Microglia in Alzheimer’s Disease: A CiteSpace Analysis
Wang, Q., Zhang, X. C., Wang, D., Jiang, X., Zhou, Y., Zhang, T., Yang, X., Liu, L.-Z., & Li, Q. (2025) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s521350 · Cited by 1
Role of nuclear import proteins in maintaining proteostasis and disease pathogenesis
Zhao, X., Pu, L., Zeng, X., & Nie, J. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117831 · Cited by 1
Wang, R., Feng, Y., Zhou, Z., Jiang, J., Zhang, R., Zou, W., Yang, H., Lv, W., & Shen, Y. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1748418 · Cited by 2
Optic Nerve Head Spatial Transcriptomic Change in Nonhuman Primate Early Experimental Glaucoma
Williams, G. A., Lee, J., Zangirolani, G. M., Reynaud, J. F., Yang, H., Marsh‐Armstrong, N., Burgoyne, C. F., & Chaudhary, P. (2026) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.67.3.22 · Cited by 1
Cell-type-specific APOE4 cascade across the Alzheimer’s disease continuum
Shostak, D. M., Liang, Z., & Huang, Y. (2026) · Neuron · doi:10.1016/j.neuron.2026.04.024 · Cited by 1
Pasten-Castrejón, N. J., Martínez-Orozco, H., Gutiérrez-Silerio, G. Y., Hernández-Montiel, H. L., Maya-Arteaga, J. P., Poblano-Paez, I., García‐Solís, P., & Díaz-Miranda, S. Y. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27115022 · Cited by 1
Gadd, D. A., McGeachan, R. I., Hillary, R. F., McCartney, D. L., Harris, S. E., Sherwood, R. A., Abbott, N. J., Cox, S. R., & Marioni, R. E. (2022) · Wellcome Open Research · doi:10.12688/wellcomeopenres.17322.2 · Cited by 1
An Alternate View of Neuroprotection with Peptides in Alzheimer’s Disease
King, S. P., & Suphioglu, C. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.91065 · Cited by 1
The “DAMPome” as a Key Player in the Pathogenesis of Human Diseases
Land, W. G. (2020) · Springer eBooks · doi:10.1007/978-3-030-53868-2_12 · Cited by 1
Guan, F., Gao, Q., Gu, J., Dai, X., Li, L., & Bao, R. (2021) · Research Square · doi:10.21203/rs.3.rs-1031757/v1 · Cited by 1
Metadata
- Authors
- Venegas, C., & Heneka, M. T.
- Affiliations
- University of Bonn (DE)
- Corresponding author
- Heneka, Michael T
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-10-21
- Volume
- 101
- Issue
- 1
- Pages
- 87-98
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2534771646
- Cited by
- 236
- References
- 156
- Citations by year
- 2026: 24 · 2025: 26 · 2024: 29 · 2023: 25 · 2022: 29 · 2021: 30 · 2020: 30 · 2019: 15 · 2018: 15 · 2017: 11
- FWCI
- 1.20
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Leukocyte Biology (publishedVersion)
- PubMed (publishedVersion)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion)
- DZNE Pub (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- damage-associated molecular patterns, Alzheimer's disease, innate immunity, pattern recognition receptors, pathogen-associated molecular patterns, inflammasome, amyloid-beta, HMGB1, S-100 protein, chromogranin A, nucleic acids, neuroinflammation, cytokine production
- MeSH terms
- Alarmins, Alzheimer Disease, Animals, Humans, Inflammation, Models, Biological, Receptors, Pattern Recognition, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review